Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Royal Maxim Palace Kempinski

Oct 14, 2019 1:30 PM - Oct 15, 2019 11:30 PM

1st Settlement, Eastern Ring Road, New Cairo, 11477, Egypt

DIA Middle East Regulatory Conference (MERC)

The collaborative platform for connecting Regulatory experts in the Middle East

Session 5: HTA 2.0: a Glimpse into Current uses and Future Trends

Session Chair(s)

Mourad  Aboubakr

Mourad Aboubakr

MENA Regional Head Market Access, Novartis, United Arab Emirates

Noha  Salem

Noha Salem

Regional Director for Healthcare Policy, EEMEA, MSD, Egypt

Recently, HTA has become one of the most important topics across the region as governments aspire to modernize healthcare systems and adopt contemporary measures for evaluating healthcare interventions. This session will shed light on the past, present and future of HTA through the participation of industry, international bodies, government and academic experts, and the discussion of topics such as lessons from the past, the current state of play and recommendations for moving towards a value-based system and integrating HTA into the broader healthcare context.

Speaker(s)

Ansgar  Hebborn, PHD, MBA

Ansgar Hebborn, PHD, MBA

Head - Access Policy Affairs Europe, F. Hoffmann-La Roche AG, Switzerland

EUnetHTA – Where and Why it Started & Lessons Learned - Remote Presentation

Anna-Eva  Ampelas, LLM

Anna-Eva Ampelas, LLM

Head of Unit, Unit B6 Medical Devices and Health Technology Assessment, DG SANTE, European Commission, Belgium

How to get to an international approach in HTA – Video contribution

Ibrahim A. Al Juffali

Ibrahim A. Al Juffali

Advisor to the Minister of Health for Pharmaceutical Sector Development, Assistant Professor, Department of Pharmaceutics, College of Pharmacy, King Saud, Saudi Arabia

Health Technology Assessment in Saudi Arabia: Experts Perception on the Creation of a National HTA Entity

Mourad  Aboubakr

Mourad Aboubakr

MENA Regional Head Market Access, Novartis, United Arab Emirates

Health Technology Assessment: the Innovation Industry Perspective

Panos  Kanavos

Panos Kanavos

Deputy Director, LSE Health, London School of Economics, United Kingdom

HTA in the Middle East region – A mapping of the current landscape and options for the future

Shaimaa  Foad

Shaimaa Foad

Pharmacoeconomic Unit, Central Administration of Pharmaceutical Affairs (CAPA) Egypt, Egypt

Q&A and Panel discussion on Implementing the right HTA system: pitfalls, best-practices and recommendations, with the participation of:

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.